Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer

Bing Guan; Kaijie Wu; Jin Zeng; Shan Xu; Lijun Mu; Yang Gao; Ke Wang; Zhenkun Ma; Juanhua Tian; Qi Shi; Peng Guo; Xinyang Wang; Dalin He; Yuefeng Du

doi:10.18632/oncotarget.28206

Correction: Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer

Oncotarget. 2022 Mar 7:13:507. doi: 10.18632/oncotarget.28206. eCollection 2022.

Authors

Bing Guan^{1

2}, Kaijie Wu^{1

3

2}, Jin Zeng^{1

3}, Shan Xu^{1

3}, Lijun Mu¹, Yang Gao¹, Ke Wang^{1

3}, Zhenkun Ma^{1

3}, Juanhua Tian¹, Qi Shi¹, Peng Guo^{1

3}, Xinyang Wang^{1

3}, Dalin He^{1

3}, Yuefeng Du^{1

3}

Affiliations

¹ Department of Urology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
² These authors have contributed equally to this work.
³ Oncology Research Laboratory, Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an, Shaanxi, China.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.14131.].

Publication types

Published Erratum